Northern Trust EAFE Index (S:0P00006UZZ)
65.96
+0.41
(+0.63%)
USD |
Nov 30 2025
Returns Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Key Stats
Basic Info
| Investment Strategy | |
| None |
| General | |
| Security Type | None |
| Equity Style | None |
| Fixed Income Style | None |
| Broad Asset Class | None |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Fund Owner Firm Name | None |
| Broad Asset Class Benchmark Index | |
| None | |
Annual Total Returns Versus Peers
As of December 26, 2025.
Asset Allocation
| Type | % Net |
|---|---|
| Cash | -- |
| Stock | -- |
| Bond | -- |
| Convertible | -- |
| Preferred | -- |
| Other | -- |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| ASML Holding NV | 1.95% | 1050.00 | -1.87% |
| SAP SE | 1.43% | 239.51 | -2.24% |
| HSBC Holdings Plc | 1.25% | 15.80 | -0.47% |
| Novartis AG | 1.22% | 138.87 | 3.83% |
| Nestlé SA | 1.21% | 97.10 | -1.61% |
| AstraZeneca PLC | 1.19% | 181.28 | -2.75% |
| Roche Holding AG | 1.17% | 422.74 | 1.79% |
| Shell Plc | 1.07% | 36.61 | 0.92% |
| Siemens AG | 1.04% | 286.78 | -0.41% |
| Mitsubishi UFJ Financial Group, Inc. | 0.95% | 16.15 | -0.98% |
Fees & Availability
| Fees | |
| Negotiable Fee | -- |
| Maximum Management Fee | -- |
| Prospectus Custodian Fee | -- |
| Purchase Details | |
| Open to New Investors | -- |
Basic Info
| Investment Strategy | |
| None |
| General | |
| Security Type | None |
| Equity Style | None |
| Fixed Income Style | None |
| Broad Asset Class | None |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Fund Owner Firm Name | None |
| Broad Asset Class Benchmark Index | |
| None | |
Fundamentals
| General | |
| Number of Holdings | -- |
| Stock | |
| Weighted Average PE Ratio | -- |
| Weighted Average Price to Sales Ratio | -- |
| Weighted Average Price to Book Ratio | -- |
| Weighted Median ROE | -- |
| Weighted Median ROA | -- |
| Number of Equity Holdings | -- |
Fund Details
| Key Dates | |
| Inception Date | -- |
| Attributes | |
| Socially Responsible Fund | -- |